RE:RE:RE:AEZS approached CZOAEZS put the squeeze on CZO after Q2 results were released and the new company then became a 50/50 split. No doubt that any positive news for CEAPRO such as the commercial licensing of CoQ10 in H2 or AV phase 1/2a results (if started on time) would have led to re-negotiating this ratio, or the potential termination of the agreement. Gilles really wanted this deal which would stroke his ego to be a CEO of a NASDAQ listed biopharma company.
OATS you and your group can put an end to this sham of a merger and let shareholders take back the company. Gilles has proven he has no credibility. Don't be persuaded by his hollow words.